Updating results

98 results for Anticoagulation Sort: Relevance | Date

Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (CG144)

Evidence-based recommendations on diagnosing and managing venous thromboembolic diseases (VTE, deep vein thrombosis, DVT, blood clots) in adults

Clinical guideline Published June 2012 Last updated November 2015

Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (CG68)

Evidence-based recommendations on the diagnosis and initial management of stroke and transient ischaemic attack (TIA or ‘mini-stroke’) in over 16s

Clinical guideline Published July 2008 Last updated March 2017

Atrial fibrillation

Everything NICE has said on diagnosing and managing atrial fibrillation in an interactive flowchart

NICE Pathway Published June 2014 Last updated November 2018

Structural heart defects

Everything NICE has said on structural heart defects in an interactive flowchart

NICE Pathway Published November 2013 Last updated August 2018

Atrial fibrillation (QS93)

Evidence-based statements to deliver quality improvements in the identification, treatment and management of atrial fibrillation (AF) in adults

Quality standard Published July 2015 Last updated February 2018

Venous thromboembolism

Everything NICE has said on assessing, diagnosing, treating and reducing the risk of venous thromboembolism in adults in an interactive flowchart

NICE Pathway Published May 2011 Last updated March 2018

Blood transfusion (NG24)

This guideline covers the assessment for and management of blood transfusions in adults, young people and children over 1 year old.

NICE guideline Published November 2015

Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation (TA256)

Evidence-based recommendations on rivaroxaban (Xarelto) for preventing stroke and systemic embolism in atrial fibrillation (AF)

Technology appraisal guidance Published May 2012

Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism (TA287)

Evidence-based recommendations on rivaroxaban (Xarelto) for treating pulmonary embolism and preventing recurrent venous thromboembolism

Technology appraisal guidance Published June 2013

Proportion of patients with atrial fibrillation on anticoagulation admitted to hospital for stroke

Proportion of patients with atrial fibrillation on anticoagulation admitted to hospital for stroke Subject(s): Atrial fibrillation

CCG indicator Published November 2017

Proportion of patients with atrial fibrillation not on anticoagulation admitted to hospital for stroke.

Proportion of patients with atrial fibrillation not on anticoagulation admitted to hospital for stroke. Subject(s): Atrial fibrillation

CCG indicator Published July 2016

Aortic valve reconstruction with processed bovine pericardium (IPG604)

Evidence-based recommendations on aortic valve reconstruction with processed bovine pericardium (using new valve made from chemically treated cow pericardium)

Interventional procedures guidance Published February 2018

Dronedarone for the treatment of non-permanent atrial fibrillation (TA197)

Evidence-based recommendations on dronedarone (Multaq) for treating non-permanent atrial fibrillation (AF)

Technology appraisal guidance Published August 2010 Last updated December 2012

Major trauma: assessment and initial management (NG39)

Evidence-based recommendations for pre-hospital and hospital settings, including ambulance services, emergency departments, major trauma centres and trauma...

NICE guideline Published February 2016

Andexanet alfa for reversing anticoagulation [ID1101]

In development [GID-TA10440] Expected publication date: TBC

Technology appraisal guidance In development

Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation (TA275)

Evidence-based recommendations on apixaban (Eliquis) for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation (AF)

Technology appraisal guidance Published February 2013

Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) (DG14)

Evidence-based recommendations on point-of-care coagulometers (the CoaguChek XS system) to self-monitor blood clotting

Diagnostics guidance Published September 2014 Last updated December 2017

Thoracoscopic exclusion of the left atrial appendage (with or without surgical ablation) for non-valvular atrial fibrillation for the prevention of thromboembolism (IPG400)

Evidence-based recommendations on thoracoscopic exclusion of the left atrial appendage (with or without surgical ablation) for non-valvular atrial fibrillation

Interventional procedures guidance Published June 2011

Long-term versus 3-month oral anticoagulation treatment in subgroups of patients at increased risk of VTE recurrence:- What is the clinical and cost effectiveness of long-term oral anticoagulation treatment in specific subgroups of patients with a first unprovoked VTE?

Recommendation ID CG144/2 Question Long-term versus 3-month oral anticoagulation treatment in subgroups of patients at increased risk of...

Research recommendation Published June 2015

Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation (TA249)

Evidence-based recommendations on dabigatran etexilate (Pradaxa) for preventing stroke and systemic embolism in atrial fibrillation (AF)

Technology appraisal guidance Published March 2012

Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism (IPG349)

Evidence-based recommendations on percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation to prevent stroke

Interventional procedures guidance Published June 2010

Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults (TA245)

Evidence-based recommendations on apixaban (Eliquis) for preventing venous thromboembolism (VTE) after total hip or knee replacement in adults

Technology appraisal guidance Published January 2012

Percutaneous balloon cryoablation for pulmonary vein isolation in atrial fibrillation (IPG427)

Evidence-based recommendations on percutaneous balloon cryoablation for pulmonary vein isolation in atrial fibrillation (AF)

Interventional procedures guidance Published May 2012

Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (TA355)

Evidence-based recommendations on edoxaban (Lixiana) for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (AF)

Technology appraisal guidance Published September 2015

Transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesis (IPG541)

Evidence-based recommendations on transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesis

Interventional procedures guidance Published December 2015

Percutaneous closure of patent foramen ovale to prevent recurrent cerebral embolic events (IPG472)

Evidence-based recommendations on percutaneous closure of patent foramen ovale (PFO/hole in the heart) to prevent recurrent cerebral embolic events

Interventional procedures guidance Published December 2013

NICE impact: cardiovascular disease prevention

How NICE recommendations are helping to improve the prevention of cardiovascular disease

Published May 2018

Percutaneous transluminal radiofrequency sympathetic denervation of the renal artery for resistant hypertension (IPG418)

Evidence-based recommendations on percutaneous transluminal radiofrequency sympathetic denervation of the renal artery for resistant hypertension

Interventional procedures guidance Published January 2012

KTT16: Anticoagulants, including non-vitamin K antagonist oral anticoagulants (NOACs)

of atrial fibrillation, assessment of stroke and bleeding risks and anticoagulation, and the NICE patient decision aid. The absence of...

Key therapeutic topic Published February 2016 Last updated February 2018

Thrombolytic therapy for DVT:- What is the clinical and cost effectiveness of clot removal using catheter-directed thrombolytic therapy or pharmacomechanical thrombolysis compared with standard anticoagulation therapy for the treatment of acute proximal DVT?

thrombolytic therapy or pharmacomechanical thrombolysis compared with standard anticoagulation therapy for the treatment of acute...

Research recommendation Published June 2015

Stent placement for vena caval obstruction (IPG79)

Evidence-based recommendations on stent placement for vena caval obstruction

Interventional procedures guidance Published July 2004

Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults (TA170)

Evidence-based recommendations on rivaroxaban (Xarelto) for the prevention of venous thromboembolism after total hip or knee replacement in adults

Technology appraisal guidance Published April 2009

Resources for STPs and ICSs

Resources for STPs and ICSs

Published October 2018

Improving anticoagulation in atrial fibrillation (AF): Primary care interventions

Shared learning Published May 2014 Last updated April 2015

Percutaneous radiofrequency ablation for atrial fibrillation (IPG168)

Evidence-based recommendations on percutaneous radiofrequency ablation for atrial fibrillation (AF)

Interventional procedures guidance Published April 2006

Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence (CG76)

Evidence-based recommendations on involving patients in decisions about prescribed medicines and supporting adherence for people aged 18 and over

Clinical guideline Published January 2009

Chronic heart failure in adults: diagnosis and management (NG106)

Evidence-based recommendations on diagnosing and managing chronic heart failure in people aged 18 and over

NICE guideline Published September 2018

Percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for atrial fibrillation (IPG294)

Evidence-based recommendations on percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for atrial fibrillation (AF)

Interventional procedures guidance Published March 2009